ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0295

Association of Serum Uric Acid with Early Albuminuria in Adults Without Diabetes or CKD: An NHANES Analysis

Session Information

Category: CKD (Non-Dialysis)

  • 2201 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Mace de Lepinay, Beatrice, NYC Health and Hospitals Elmhurst, Elmhurst, New York, United States
  • Margalioth, Jonathan, NYC Health and Hospitals Elmhurst, Elmhurst, New York, United States
  • Mc Daid, Alexander Andrew, NYC Health and Hospitals Elmhurst, Elmhurst, New York, United States
  • Stern, Aaron S., NYC Health and Hospitals Elmhurst, Elmhurst, New York, United States
Background

Elevated serum uric acid has been associated with chronic kidney disease (CKD) progression and albuminuria in high-risk populations, but its relationship with early kidney injury in adults without diabetes or CKD remains unclear. We evaluated the association between serum uric acid and albuminuria in a nationally representative sample of U.S. adults without overt kidney disease.

Methods

We conducted a cross-sectional analysis of adults from the National Health and Nutrition Examination Survey (NHANES) 2007–2018. Individuals with CKD (eGFR <60 mL/min/1.73 m2) or diabetes were excluded. Serum uric acid was analyzed continuously and by quartiles. The primary outcome was albuminuria (defined as UACR ≥30 mg/g). Survey-weighted logistic regression models were used to estimate the association between serum uric acid and albuminuria, adjusting for age, sex, race/ethnicity, body mass index, and hypertension. Because hypertension may represent both a contributor to and manifestation of kidney injury, hypertensive individuals were not excluded; instead, stratified analyses were conducted by hypertension status. Sensitivity analyses excluded individuals with severe obesity (BMI ≥40 kg/m2) and gout. Secondary analyses evaluated log-transformed UACR as a continuous outcome.

Results

Higher serum uric acid was independently associated with albuminuria, with each 1 mg/dL increase associated with 19% higher odds (OR 1.19, 95% CI 1.12–1.29, p<0.001). This association remained significant after excluding individuals with severe obesity and gout and after adjustment for hypertension. In stratified analyses, the association remained significant in both normotensive and hypertensive individuals and was slightly stronger among participants without hypertension (OR 1.22, 95% CI 1.12–1.32 vs. OR 1.16, 95% CI 1.07–1.25). In secondary analyses evaluating continuous log-transformed UACR, higher serum uric acid levels remained independently associated with increased urinary albumin excretion (β = 0.020, p = 0.002), supporting a graded relationship between uric acid and early kidney injury.

Conclusion

Elevated serum uric acid was independently associated with early albuminuria in adults without diabetes or CKD. These findings suggest that uric acid may be linked to early renal injury prior to overt CKD and may represent a marker of subclinical kidney dysfunction.